PubMed COVID-19 Clinical Care

No abstract

No abstract

CONCLUSION: This study demonstrates the breadth of anti-S1 antibodies elicited by vaccination at the proteome level, and identifies stereotypical restriction of IGHV utilisation in the IgG repertoire in PAD compared with HC subjects. Despite

CONCLUSIONS: Telehealth use increased among a variety of practice types during the pandemic with no variation observed by practice location for modalities used, future preferences, or needs. To the best of our knowledge, this is one of few studies

Fear of a fresh infection wave and a global health issue in the ongoing COVID-19 pandemic have been rekindled by the appearance of two new novel variants BF.7 and BA.4/5 of Omicron lineages. Predictions of increased antibody evasion capabilities and

PF-07321332 and PF-07304814, inhibitors against SARS-CoV-2 developed by Pfizer, exhibit broad-spectrum inhibitory activity against the main protease (M^(pro)) from various coronaviruses. Structures of PF-07321332 or PF-07304814 in complex with M^(pro

No abstract

CONCLUSIONS: BPLM demonstrated that a virtual platform can successfully engage Black communities. Incorporating clergy and religious organizations was critical in developing the trust of the Black community towards BPLM.

CONCLUSION: This case may indicate that coronavirus disease 2019 was already spreading in Germany as early as December 2019.

CONCLUSIONS: The success of our approach illustrates that pooling information between the ILI and COVID-19 leads to improved forecasting models than individual models for either of the disease.